Clinical Trial Update: Safety/Efficacy of Letrozole Monotherapy or in Combination With Zoledronic Acid as Extended Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial assessing letrozole as monotherapy or in combination with zoledronic acid as extended adjuvant therapy in postmenopausal patients with primary bre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Osteoporosis

Drugs mentioned

• FEMARA (letrozole)
• Zometa (Zoledronic acid)

Snippet

Sponsor: Novartis | Conditions: Osteoporosis, Postmenopausal | Phase 3 | Status: COMPLETED | Results posted: 2011-11-16